These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4559743)

  • 1. Influenza immunization: field trial on a university campus.
    Waldman RH; Coggins WJ
    J Infect Dis; 1972 Sep; 126(3):242-8. PubMed ID: 4559743
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine.
    Waldman RH; Mann JJ; Small PA
    JAMA; 1969 Jan; 207(3):520-4. PubMed ID: 5818213
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum antibodies and local antibodies after subcutaneous or intranasal influenza vaccination].
    Nicolas A; Pasquier P; Peyron L; Triau R; Werner GH
    C R Acad Hebd Seances Acad Sci D; 1973 Jul; 277(4):467-9. PubMed ID: 4206634
    [No Abstract]   [Full Text] [Related]  

  • 6. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.
    Sugiura A; Yanagawa H; Enomoto C; Ueda M; Tobita K
    J Infect Dis; 1970 Dec; 122(6):472-8. PubMed ID: 5496135
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization.
    Foy HM; Cooney MK; McMahan R; Bor E; Grayston JT
    JAMA; 1971 Aug; 217(8):1067-71. PubMed ID: 5109428
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of intranasal and parenteral immunization routes for influenza in mice.
    Provost PJ; DeMello GC; Vasington PJ
    Can J Microbiol; 1971 Aug; 17(8):1119-24. PubMed ID: 5096403
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of partial immunity to influenza by a neuraminidase-specific vaccine.
    Couch RB; Kasel JA; Gerin JL; Schulman JL; Kilbourne ED
    J Infect Dis; 1974 Apr; 129(4):411-20. PubMed ID: 4593871
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of influenza anti-neuraminidase antibody on virus neutralization.
    Kasel JA; Couch RB; Gerin JL; Schulman JL
    Infect Immun; 1973 Jul; 8(1):130-1. PubMed ID: 4718922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic response to influenza virus in man. II. Neutralizing antibody response to inactivated monovalent B vaccine, with observations on vaccine efficacy during a subsequent type B epidemic.
    Brown P; Gajdusek DC; Chen KM; Morris JA
    Am J Epidemiol; 1969 Oct; 90(4):336-43. PubMed ID: 5823444
    [No Abstract]   [Full Text] [Related]  

  • 12. Nasal immunization of asthmatic children with killed influenza virus.
    Newcomb RW; Eller JJ
    J Allergy; 1971 Apr; 47(4):220-9. PubMed ID: 5280154
    [No Abstract]   [Full Text] [Related]  

  • 13. Further trials of live influenza vaccine.
    Andrews BE; Beare AS; McDonald JC; Zuckerman AJ; Tyrrell DA
    Br Med J; 1966 Mar; 1(5488):637-40. PubMed ID: 5908709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serological response to the subcutaneous or intranasal administration of attenuated influenza virus vaccine].
    Guibert J; Peyron L; Cherby J; Nicolas A; Pasquier P; Werner H
    C R Acad Hebd Seances Acad Sci D; 1970 Jun; 270(25):3166-9. PubMed ID: 4988163
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of influenza infections.
    Iacuzio D
    Adv Intern Med; 2001; 46():51-76. PubMed ID: 11147260
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of influenza immunization: influence of route of administration and vaccine strain.
    Waldman RH; Bond JO; Levitt LP; Hartwig EC; Prather EC; Baratta RL; Neill JS; Small PA
    Bull World Health Organ; 1969; 41(3):543-8. PubMed ID: 4908340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research on influenza vaccination with A2 + B vaccine].
    Bellelli E; Nardi G; Bracchi U; Tanzi ML; Monaci V; Sansebastiano G
    Ann Sclavo; 1971; 13(5):584-96. PubMed ID: 5153401
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic response to influenza virus in man. I. Neutralizing antibody response to inactivated monovalent A2 vaccine as related to prior influenza exposure.
    Brown P; Gajdusek DC; Morris JA
    Am J Epidemiol; 1969 Oct; 90(4):327-35. PubMed ID: 5823443
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 20. ANTIGENIC VARIATION OF RECENTLY ISOLATED A2 INFLUENZA VIRUSES.
    WEINBERGER HL; BUESCHER EL; MCCOWN J; GAULD JR
    Proc Soc Exp Biol Med; 1963 Nov; 114():413-20. PubMed ID: 14101205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.